Literature DB >> 9067099

Cytologic and fluorescence in situ hybridization (FISH) examination of metanephric adenoma.

A A Renshaw1, D Maurici, J A Fletcher.   

Abstract

Metanephric adenoma is a recently described benign renal neoplasm with distinctive histologic features. The cytologic appearance and fluorescence in situ hybridization (FISH) studies of this tumor have not been described. We present a case from a 48-yr-old woman. Cytologically, the cells were arranged in tight, short papillae and loose sheets. The cells had scant cytoplasma, round monotonous nuclei with fine even chromatin and rare small nucleoli. Immunohistochemistry revealed no reactivity for epithelial membrane antigen (EMA), keratins (AE1/AE3, callus, 34BE12), or carcinoembryonic antigen (CEA). FISH showed a disomic pattern for chromosomes 7, 17, and for the chromosome 3 short arm. The differential diagnosis includes Wilms' tumor, renal adenoma, papillary renal cell carcinoma, and metastatic tumors. Both immunohistochemistry and FISH may be of help in distinguishing some of these lesions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067099     DOI: 10.1002/(sici)1097-0339(199702)16:2<107::aid-dc2>3.0.co;2-e

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  3 in total

Review 1.  Metanephric adenoma of the kidney: case report and review of the literature.

Authors:  H U Schmelz; M Stoschek; M Schwerer; B Danz; E W Hauck; W Weidner; C Sparwasser
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Cytologic features of metanephric adenoma of the kidney.

Authors:  José A Jiménez-Heffernan; Eva Tejerina; Pilar González-Peramato; Blanca Vicandi; Ana López-García
Journal:  Cytojournal       Date:  2009-04-04       Impact factor: 2.091

3.  Metanephric Adenoma: clinical, imaging, and Histological findings.

Authors:  Fábio César Miranda Torricelli; Giovanni Scala Marchini; Rodrigo Sousa Madeira Campos; Antônio Otero Gil
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.